Posted on Leave a comment

Xavant Technology Announces First Dual-Sensor Neuromuscular Patient Monitor

The Stimpod NMS450X NMT monitor for Anesthesia first to feature both AMG and EMG modalities in one single, portable patient monitoring system.  

Pretoria, South Africa, October. 15, 2019 – Xavant Technology, a pioneer in neuromuscular monitoring and innovative neuromodulation modalities, announced an addition to the company’s newest generation of Stimpod neuromuscular transmission monitor – the capability of utilizing either of the two most industry prominent types of monitoring sensors, AMG and EMG. The new Stimpod system and EMG sensor accessory will be exhibited at the American Society of Anesthesia (ASA) Annual Meeting, October 19-21 in Orlando, Florida alongside the company’s entire Stimpod portfolio for anesthesia.

“We are excited to announce the EMG modality to our Stimpod line of monitors,” stated Corlius Birkill, CEO of Xavant Technology. “By offering, for the first time, anesthesiologists and clinicians a choice in using either AMG or EMG, we can give them unparalleled clinical and budgetary benefits.” Mr. Birkill continued, “We believe quantitative or objective monitoring of patients who are undergoing neuromuscular block for surgery should be the standard of care. Our goal is to provide physicians with the most optimal and efficient tools to achieve that standard.”

The latest update to the AMG-based Stimpod NMS450X monitor series will enable the use for the first time ever, a dual sensor objective neuromuscular transmission monitor that enables anesthesiologists the choice of using either acceleromyography (AMG) with a reusable sensor or electromyography (EMG) with a disposable sensor to manage patients undergoing neuromuscular block during surgery or while being cared for in the intensive care unit.

By adding an EMG sensor accessory to the Stimpod, clinician opportunities in monitoring will be maximized. Being able to choose either AMG or EMG at site of service, hospitals can perform cost-effective entire-surgery monitoring with the platform that is optimal for that specific case. While AMG is a proven, accurate and cost-effective technology, the EMG sensor will simplify how clinicians monitor patients in more restrictive surgical cases, such as robotic surgery where restricting the hands is common. The EMG accessory is pending FDA clearance.

“The Stimpod NMT monitor is simple and economical way for hospitals to drive patient safety, Operating room, PACU, and ICU efficiency, and manage their very expensive paralytic and recovery drug budgets,” stated Xavant Chairman Roche van Rensburg. “We believe the data is fairly conclusive that hospitals can enhance safety outcomes related to residual neuromuscular block by utilizing objective NMT monitoring. But also important is the power to more effectively manage the time and cost-of-care efficacy for the hospital – we believe the Stimpod system can make a tremendous positive difference on both fronts,” added Mr. van Rensburg.

About Xavant Technology

By Xavant Technology October 17, 2019

Posted on Leave a comment

Novaerus NanoStrike Airborne Disinfection Technology

Novaerus NanoStrike Airborne Disinfection Technology

  • Table Top for Smaller Rooms ~120 sq. ft., NV200 delivers 50 CFM(Cubic Feet per Minute) airflow.
  • Wall Mountable, Pedestal Mounted or Roll Stand Mounted options for Medium Rooms ~900 sq. ft., NV900 delivers 150 CFM(Cubic Feet per Minute) airflow at fan speed 1 and 180 CFM at fan speed II.
  • Standalone for rapid remediation for larger common areas with a triple-stage Camfil filter, ~3,000 sq. ft., NV1050 delivers 533 CFM(Cubic Feet per Minute) airflow.
  • Novaerus NanoStrike Airborne Disinfection Technology protects against airborne viruses and bacteria. Nanostrike is the core, patented technology that uses Novaerus plasma-based technology killing all airborne microoganisms on contact providing protection against viruses and bacteria.

NanoStrike patented technology destroys viruses, microorganisms and bacteria at the DNA level:

  • Plasma coils create energy field that kills ALL germs and pathogens in sub-second time.
  • 99.9+% effective at eliminating Influenza pathogens, SARS-Cov-2(Covid-19), and MRSA
  • Kills ALL airborne microorganisms at the DNA level as small as 1 nanometer!
  • Total cell destruction ensures cells do not become viable as an infectious agent ever again.
  • Continuous 24/7 air disinfection and odor control with no disposables
  • Lowest cost of ownership operating 24/7 with no supplies needed for NV200 or NV900.
  • Plugs into standard power outlets plus wall mounts, pedestal stand or roll stand options
  • Independently tested and proven for use in ORs, ICUs, ED, Offices, Restaurants, etc.

 How does NanoStrike Protect?

NanoStrike utilizes an atmospheric plasma discharge like a lightning strike to kill and deactivate harmful airborne microoganisms.  NanoStrike plasma coils provide a deadly strike made up of multiple concurrent processes that work to rapidly destroy airborne pathogens.  The result is total destruction of all airborne pathogens! 

NanoStrike plasma coils create an electrostatic field bombarded by electroporation and electromagnetic field radiating heat and UV radiation in sub-second time to force cells down to one nanometer to explode with osmotic pressure resulting in total destruction of airborne pathogens. 

Novaerus does not filter virus and bacteria cells from the air it destroys them to the point of total destruction with no chance of reactivation or self-healing. 

NanoStrike can protect humans in hospitals, senior living facilities, long term care facilities, schools, locker rooms, casinos, railway stations, residences, hotel common areas, offices, manufacturing, meat processing plants and virtually any indoor environment where people gather.   

Breathe easy with Bell Medical and NanoStrike Technology.

Posted on Leave a comment

Measures to Control the Transmission of Covid-19

Ever since the first reports of Covid-19 in China (1) there has been a great deal of focus on how the virus spreads.

 It is now clear that, the virus causing COVID-19, is primarily transmitted between people through respiratory droplets and contact routes.

Droplet transmission occurs when a person is in close contact (within 1 m) of someone with respiratory symptoms (e.g. coughing or sneezing) and is therefore at risk of having their mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person. Therefore, transmission of the COVID-19 virus may occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person. (2) Studies from a variety of disciplines investigating viruses clearly support the following:

  • most respiratory and enteric viruses can survive on fomites and hands for varying lengths of time.
  •  fomites and hands can become contaminated with viruses from both natural and laboratory sources.
  •   viral transfer from fomites to hands is possible.
  •   hands come in contact with portals of entry for viral infection.

 If viruses remain viable on surfaces long enough to come into contact with a host, the virus may only need to be present in small numbers to infect the host. (3)

The virus can also be spread via airborne transmission which is different to droplet transmission. This refers to the presence of microbes within droplet nuclei. Droplet nuclei are generally considered to be particles ≤ 5μm in diameter that can remain in the air for longer periods of time and can be transmitted to others over distances greater than 1 metre. Airborne transmission of the COVID-19 virus is possible under circumstances and settings where aerosol generating procedures (AGPs) are performed. (2)

We are all aware of the measures that are being taken in the community to prevent the transmission of the virus via the droplet and contact routes. (4) But what is happening in hospitals; particularly when a patient needs emergency surgery or, as is now happening an elective or planned procedure?

In planned procedures the patient should isolate for several days and test negative for Covid-19 before entering theatre. Emergency patients are identified as symptomatic or asymptomatic and appropriate Infection Prevention and Control procedures are put in place. (5)

Much is being done in hospitals generally and more specifically in operating theatres to reduce transmission rates. While the rates of overall infection in a country may be below 1%, (6) in hospitals the rates could be anywhere between 5% and 15%. (7)

So, what more could be done in hospitals to bring the rates of infection down? In my opinion, whilst some effort is being made to reduce fomite spread of covid-19 in the operating theatre with regular disinfection and greater use of single use items, much more could be done. (8,9)

Rolls of medical tape are often to be found in the operating theatre. Studies have shown that 51 % of rolls of tape found lying around in theatre may have VRE or MRSA, so multiple resistant bacterial organisms on them, which we then apply to patients. (10) These rolls of tape may well have Covid-19 on them and if applied to the patient’s eyes may well infect them.

It would be far safer, and better practice to use our sterile, single use EyePro™ to cover the patient’s eyes (11) thereby removing a potential Covid-19 transmission route.

Many theatres make up their own bite blocks using gauze and rolls of tape on the anaesthetic trolley. All this activity carries a high risk of fomite transmission. If you use a single wrapped clean BiteMe™ with clean gloves, BiteMe™ should pose less risk compared to rolled up gauze with respect to viral transmission. (12)

Thus, by making two small changes to operating theatre procedures you could be doing so much more to reduce the potential transmission of Covid-19.

  • Use sterile single use EyePro™, the only sterile eyelid occlusion dressing available and stop using medical tape on your patient’s eyes.
  • Use single use, clean BiteMe™ as your bite block of choice and stop making your own bite blocks.

Dr Andrew Wallis

BSc., BMedSci., MBBS (hons), FANZCA

Private Anaesthetist

Member of Medical Advisory Committee, Calvary Hospital, Launceston, Tasmania.

Medical Director Innovgas Pty Ltd

References:

  1.  Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. World Health Organisation.
  2.  Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. Interim guidance 29 June 2020. World Health Organisation
  3. S. A. Boone* and C. P. Gerba. Significance of Fomites in the Spread of Respiratory and Enteric Viral Disease. Applied and Environmental Microbiology, Mar. 2007, p. 1687–1696.
  4. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific brief 09 July 2020. World Health Organisation.
  5. Operating framework for urgent and planned services in hospital settings during COVID-19. 14 May 2020. NHS England.
  6. COVID-19 situation update for the EU/EEA and the UK, as of 14 July 2020. European Centre for Disease Prevention and Control.
  7. G. Iacobucci. Covid-19: Doctors sound alarm over hospital transmissions. BMJ 2020;369. 19 May 2020.
  8. Infection prevention and control and preparedness for COVID-19 in healthcare settings. Third update – 13 May 2020. European Centre for Disease Prevention and Control.
  9. COVID-19: infection prevention and control guidance. 21st May 2020. NHS England.
  10.  Harris PN et al. Adhesive tape in the health care setting: another high-risk fomite? Med J Aust. z2012;196(1):34.
  11.  EyePro™ Brochure.
  12.  BiteMe™ Brochure.
Posted on Leave a comment

Anesthesia Hygiene – Infectious Control

Anesthesia Machine Covers Prevent Infections!


Guidance issued by Society for Healthcare Epidemiology of America (SHEA): “…explore the use of disposable covers”

Anesthesia Hygiene machine covers have tear away pouches that hold and contain contaminated supplies such as laryngoscopes and yankauer suction! The use of disposable covers is endorsed by SHEA and ASPF.

Anesthesia Hygiene Covers protect your patient and your anesthesia machine from pathogens and infectious diseases. To view videos and more information on our webpage Anesthesia Hygiene Covers and anesthesiahygiene.com .